HCA
ABMD

Harbour Capital Advisors’s Abiomed Inc ABMD Stock Holding History

Harbour Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,340
Closed -$349K – 216
2019
Q2 		$349K Buy
1,340
+640
+91% +$170K 0.15% 155
2019
Q1 		$200K Buy
+700
New +$233K 0.09% 202

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Harbour Capital Advisors's ABMD Position: Q3 2019 in Review

Harbour Capital Advisors sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,340 shares — an estimated $349K sold.

Harbour Capital Advisors first reported a position in ABMD in Q1 2019 and held it in 2 quarters. The position peaked at $349K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Harbour Capital Advisors reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Harbour Capital Advisors sold 1,340 Abiomed Inc shares in Q3 2019, an estimated $349K.
  • Harbour Capital Advisors first reported a position in Abiomed Inc in Q1 2019 and held it in 2 quarters.
  • Harbour Capital Advisors's Abiomed Inc position peaked at $349K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Harbour Capital Advisors's 13F filing for Q3 2019, filed 30 Oct 2019.